Neoadjuvant chemoimmunotherapy as a potential therapeutic option in NSCLC UICC stage IIIA with multilevel N2 disease

Lung Cancer is still one of the leading causes for cancer related death worldwide. The determination of an adequate therapeutic approach requests a precise staging, which contains computed tomography (CT) of the thorax, positron emission tomography computed tomography (PET-CT), cerebral magnetic res...

Descripción completa

Detalles Bibliográficos
Autores principales: Menghesha, Hruy, Doerr, Fabian, Schlachtenberger, Georg, Estremadoyro, Andres Amorin, Töpelt, Karin, Wahlers, Thorsten, Hekmat, Khosro, Heldwein, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399512/
https://www.ncbi.nlm.nih.gov/pubmed/36033907
http://dx.doi.org/10.1016/j.rmcr.2022.101728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399512/
https://www.ncbi.nlm.nih.gov/pubmed/36033907
http://dx.doi.org/10.1016/j.rmcr.2022.101728

Ejemplares similares